Brookline Capital Initiates Coverage On Biomea Fusion with Buy Rating, Announces Price Target of $10

Benzinga Newsdesk www.benzinga.com Positive 50.3%

Neg 0% Neu 0% Pos 50.3%

Brookline Capital analyst Kumaraguru Raja initiates coverage on Biomea Fusion (NASDAQ:BMEA) with a Buy rating and announces Price Target of $10.